Ratings by SVB Leerink (Roanna Ruiz)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/19/2022 Enanta Pharmaceuticals ENTA Maintain Market Perform
(N/A)
 
 
  Details
5/5/2022 Aligos Therapeutics Inc. ALGS Downgrade Market Perform
(Outperform)
1.24
(1.19)
-4.03% Details
5/5/2022 Amarin Corporation AMRN Downgrade Market Perform
(Outperform)
1.56
(1.36)
-12.82% Details
3/15/2022 Pardes Biosciences PRDS New Coverage Outperform
(N/A)
5.64
(6.24)
10.64% Details
3/11/2022 Aligos Therapeutics Inc. ALGS Maintain Outperform
(N/A)
 
 
  Details
1/31/2022 Amarin Corporation AMRN Maintain Outperform
(N/A)
 
 
  Details
12/31/2021 Xeris Pharmaceuticals XERS Maintain Outperform
(N/A)
 
 
  Details
11/18/2021 Atea Pharmaceuticals AVIR Downgrade Market Perform
(Outperform)
8.69
(7.34)
-15.54% Details
11/17/2021 Xeris Pharmaceuticals XERS New Coverage Outperform
(N/A)
2.39
(1.97)
-17.57% Details
9/9/2021 Atea Pharmaceuticals AVIR New Coverage Outperform
(N/A)
27.70
(7.34)
-73.5% Details
9/9/2021 Amarin Corporation AMRN New Coverage Outperform
(N/A)
5.15
(1.36)
-73.59% Details
9/9/2021 Myovant Sciences Ltd. MYOV New Coverage Market Perform
(N/A)
25.81
(9.79)
-62.07% Details
9/9/2021 Aligos Therapeutics Inc. ALGS New Coverage Outperform
(N/A)
15.31
(1.19)
-92.23% Details
9/9/2021 ContraFect Corp. CFRX New Coverage Outperform
(N/A)
3.90
(3.24)
-16.92% Details
9/9/2021 Enanta Pharmaceuticals ENTA New Coverage Market Perform
(N/A)
57.17
(38.72)
-32.27% Details
9/9/2021 scPharmaceuticals SCPH New Coverage Market Perform
(N/A)
5.95
(5.10)
-14.29% Details